To assess the therapeutic efficiency of TRA-liposomes encapsulating DOX, the MTT assay was performed using both SKBR3 (HER2 +) and MDA-MB-231 (HER2-) breast cancer cell lines. Here, ERBB2 is linked to breast cancer.